Aytu Biopharma, Inc.
AYTU
$2.13
-$0.05-2.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.44M | -13.07M | -13.56M | 1.64M | -5.24M |
| Total Depreciation and Amortization | 4.30M | 4.71M | 5.24M | 5.50M | 5.72M |
| Total Amortization of Deferred Charges | 111.00K | 110.00K | 108.00K | 216.00K | 350.00K |
| Total Other Non-Cash Items | 23.94M | 12.12M | 12.28M | -3.75M | -2.90M |
| Change in Net Operating Assets | -4.50M | -5.23M | -6.00M | -9.14M | 2.75M |
| Cash from Operations | -595.00K | -1.37M | -1.94M | -5.53M | 673.00K |
| Capital Expenditure | -103.00K | -92.00K | -228.00K | -540.00K | -471.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 151.00K | 668.00K | 668.00K | 668.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00M | -3.00M | -3.00M | 295.00K | 250.00K |
| Cash from Investing | -3.10M | -2.94M | -2.56M | 423.00K | 447.00K |
| Total Debt Issued | 6.92M | 12.46M | 8.53M | 21.45M | 15.45M |
| Total Debt Repaid | -1.86M | -1.86M | -1.86M | -17.05M | -16.07M |
| Issuance of Common Stock | 14.84M | 14.84M | 14.84M | 3.38M | 3.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.58M | -8.62M | -6.07M | -4.27M | -3.01M |
| Cash from Financing | 13.33M | 16.83M | 15.44M | 3.52M | -251.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.63M | 12.52M | 10.95M | -1.59M | 869.00K |